Edition:
United States

Profile: Active Biotech AB (ACTI.ST)

ACTI.ST on Stockholm Stock Exchange

11.80SEK
11:29am EDT
Change (% chg)

-0.30kr (-2.48%)
Prev Close
12.10kr
Open
11.80kr
Day's High
12.00kr
Day's Low
11.75kr
Volume
28,968
Avg. Vol
47,720
52-wk High
17.30kr
52-wk Low
7.50kr

Active Biotech AB is a Sweden-based company that focuses on pharmaceutical research and development in medical fields in which the immune system plays a central role. The Company’s research portfolio primarily includes projects for the development of drugs for the treatment of autoimmune and inflammatory diseases and cancer. As of December 31, 2011, Active Biotech had five projects in clinical phase, three of which were outlicensed. Three of the projects relate to drugs for the treatment of the autoimmune diseases, multiple sclerosis (MS), Crohn’s disease, Systemic Sclerosis and rheumatoid arthritis (RA), and two of the projects focus on drugs for the treatment of cancer, mainly renal cell cancer and prostate cancer. As of December 31, 2011, the Company had three subsidiaries, including Active Forskaren 1 KB, Actinova AB and Active Security Trading AB.

Company Address

Active Biotech AB

Scheelevagen 22
LUND     223 63
P: +4646.192000
F: +4646.191100

Company Web Links